Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 88.72
+3.09 (3.61%)
Aug 4, 2025, 3:29 PM IST
Accolade Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 2.03 billion as of August 4, 2025. Its market cap has decreased by -1.31% in one year.
Market Cap
2.03B
Enterprise Value
2.27B
Revenue
1.46B
Ranking
n/a
PE Ratio
48.65
Stock Price
$88.72
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 2.03B, an increase of 18,515.21%. That is a compound annual growth rate of 162.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.03B | 8.53% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | 4.04B | 37,041.30% |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |